<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">840389</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2022.840389</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Dynamic Mitochondrial Proteome Under Polyamines Treatment in Cardiac Aging</article-title>
<alt-title alt-title-type="left-running-head">Zhang et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Polyamines in Aging Heart</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1705808/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Meng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1580964/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Ting</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Peiling</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chai</surname>
<given-names>Nannan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Lingxu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Junying</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Xue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1667925/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiu</surname>
<given-names>Bintao</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhao</surname>
<given-names>Yajun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1604252/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pathophysiology</institution>, <institution>Key Laboratory of Cardiovascular Medicine Research</institution>, <institution>Harbin Medical University</institution>, <addr-line>Harbin</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pathology</institution>, <institution>The First Affiliated Hospital of Soochow University</institution>, <institution>Soochow University</institution>, <addr-line>Suzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>College of Nursing</institution>, <institution>Medical School of Chifeng University</institution>, <addr-line>Chifeng</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Nephrology</institution>, <institution>The Second Affiliated Hospital of Hainan Medical University</institution>, <addr-line>Haikou</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Medical Technology</institution>, <institution>Beijing Health Vocational College</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Pathophysiology</institution>, <institution>Qiqihar Medical University</institution>, <addr-line>Qiqihar</addr-line>, <country>China</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Medical Research Center</institution>, <institution>Peking Union Medical College Hospital</institution>, <institution>Chinese Academy of Medical Sciences</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/532292/overview">Lingjun Wang</ext-link>, Guangzhou University of Chinese Medicine, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1347820/overview">Zixin Chen</ext-link>, Guangzhou University of Chinese Medicine, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1610611/overview">Hongcheng Fang</ext-link>, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/502020/overview">Bhupesh Singla</ext-link>, University of Tennessee Health Science Center (UTHSC), United&#x20;States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yajun Zhao, <email>100070@hrbmu.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work.</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>840389</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>12</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>02</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zhang, Yan, Liu, Wei, Chai, Li, Wang, Yu, Lin, Qiu and Zhao.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhang, Yan, Liu, Wei, Chai, Li, Wang, Yu, Lin, Qiu and Zhao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Age-related alteration of mitochondria causes impaired cardiac function, along with cellular and molecular changes. Polyamines can extend the life span in mice. However, whether polyamines can affect the dynamic mitochondrial proteome, thereby preventing age-related changes in cardiac function and cardiac aging, remains unclear. In this study, we found that spermine (Spm) and spermidine (Spd) injection for 6&#xa0;weeks could prevent 24-month-old rats heart dysfunction, improve mitochondrial function, and downregulate apoptosis. Using iTRAQ tools, we identify 75 mitochondrial proteins of statistically significant alteration in aging hearts, which mainly participate in important mitochondrial physiological activity, such as metabolism, translation, transport, apoptosis, and oxidative phosphorylation. Moreover, four proteins of differential expression, pyruvate dehydrogenase kinase (PDK4), trifunctional enzyme subunit alpha (HADHA), nicotinamide nucleotide transhydrogenase (NNT), and Annexin6, which were significantly associated with heart aging, were validated by Western blotting. <italic>In vitro</italic>, we further demonstrated polyamines could retard cardiomyocytes aging through downregulating the expression of PDK4 and thereby inhibiting cell apoptosis. In summary, the distinct mitochondrial proteins identified in this study suggested some candidates involved in the anti-aging of the heart after polyamines treatment, and PDK4 may provide molecular clues for polyamines to inhibit apoptosis and thus retard aging-induced cardiac dysfunction.</p>
</abstract>
<kwd-group>
<kwd>aging</kwd>
<kwd>heart</kwd>
<kwd>polyamines</kwd>
<kwd>mitochondria</kwd>
<kwd>proteome</kwd>
<kwd>rat</kwd>
</kwd-group>
<contract-num rid="cn001">81170178 82100268</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Aging is a degenerative process associated with reduction of physiological function and is the most important risk factor for developing cardiovascular disease. During aging, alteration of mitochondria trigger a wide spectrum of physiological variation, including 1) increased disorganization of mitochondrial structure, 2) decline in mitochondrial oxidative phosphorylation (OXPHOS) function, 3) accumulation of mtDNA mutation, 4) increased mitochondrial production of reactive oxygen species (ROS), and 5) increased extent of oxidative damage to DNA, proteins, and lipids (<xref ref-type="bibr" rid="B32">Lee and Wei, 2012</xref>; <xref ref-type="bibr" rid="B27">Jang et&#x20;al., 2018</xref>). Cardiac aging is an intrinsic process that results in impaired cardiac function, along with cellular and molecular changes. The mechanism of cardiac aging is sophisticated, including autophagy, ubiquitin-mediated turnover, apoptosis, mitochondrial quality control, and cardiac matrix homeostasis (<xref ref-type="bibr" rid="B51">Quarles et&#x20;al., 2015</xref>). In these processes, mitochondria have a key role because cardiac function is tightly associated with an energetically demanding process. In the last few decades, several investigations have revealed the relevance of mitochondria and oxidative stress both in cardiac aging and in the development of cardiac diseases, such as heart failure, cardiac hypertrophy, and diabetic cardiomyopathy (<xref ref-type="bibr" rid="B39">Mart&#xed;n-Fern&#xe1;ndez and Gredilla, 2016</xref>). ROS is mainly produced by mitochondria <italic>in vivo</italic>, and increases during aging (<xref ref-type="bibr" rid="B4">Bartke, 2008</xref>; <xref ref-type="bibr" rid="B50">Quan et&#x20;al., 2020</xref>). The accumulation of ROS leads to mtRNA mutation, which could develop cardiomyopathy to congestive heart failure (<xref ref-type="bibr" rid="B29">Kujoth et&#x20;al., 2007</xref>). Moreover, evidence suggests that the structure of mitochondria in the heart is broken during the aging process (<xref ref-type="bibr" rid="B12">Dai and Rabinovitch, 2009</xref>; <xref ref-type="bibr" rid="B34">Liang and Gustafsson, 2020</xref>).</p>
<p>Polyamines (PAs) are small aliphatic ploycations, existing in all living organisms, with most common members, spermine (Spm) and spermidine (Spd) (<xref ref-type="bibr" rid="B22">Haddock Russell, 1980</xref>; <xref ref-type="bibr" rid="B67">Wallace, 2009</xref>). Polyamines play multiple roles in the cellular process, such as stabilizing and remodeling chromosomes, stimulating cell proliferation, and protecting cells under different types of stress (<xref ref-type="bibr" rid="B41">Miller-Fleming et&#x20;al., 2015</xref>). Polyamines act as ROS scavengers under physiological pH (<xref ref-type="bibr" rid="B20">Fujisawa and Kadoma, 2005</xref>). By a number of studies, the mechanism of polyamines function in stress tolerance is illustrated by modulating homeostasis of ROS due to their direct, or indirect, roles in regulating antioxidant systems or suppressing ROS production (<xref ref-type="bibr" rid="B35">Liu et&#x20;al., 2015</xref>). The opening of the mitochondrial permeability transition pore (mPTP) in isolated rat heart and liver mitochondria were reported to be inhibited by polyamines (<xref ref-type="bibr" rid="B30">Lapidus and Sokolove, 1994</xref>; <xref ref-type="bibr" rid="B77">Zhao et&#x20;al., 2007</xref>). In addition, the transport of mitochondrial calcium and mitochondrial biogenesis were also influenced by polyamines (<xref ref-type="bibr" rid="B16">Elustondo et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B68">Wang et&#x20;al., 2020a</xref>). Eisenberg et&#x20;al. revealed that Spm could enhance longevity by suppression of necrosis and induction of autophagy (<xref ref-type="bibr" rid="B15">Eisenberg et&#x20;al., 2009</xref>). A recent study showed that naturally Spd has beneficial effects on cardiac aging in mice and high-salt-induced congestive heart failure in rats due to an underling mechanism (<xref ref-type="bibr" rid="B15">Eisenberg et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B14">Eisenberg et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B44">Mu&#xf1;oz-Esparza et&#x20;al., 2019</xref>). Our previous study has shown that exogenous Spm restores the intracellular polyamines pool and confers cardioprotective effect against ischemia and reperfusion (IR) injury through stabilizing the cell membrane, scavenging free radicals, and preventing intracellular free calcium elevation (<xref ref-type="bibr" rid="B77">Zhao et&#x20;al., 2007</xref>).</p>
<p>In a post-genomics age, proteomics provides powerful tools to give a global view of protein profiles in cells or tissues. In research of the aging field, <xref ref-type="bibr" rid="B9">Chakravarti et&#x20;al. (2008)</xref> discovered differential proteomic patterns for aging mouse hearts by 2DE and LC-MS/MS. Several proteomic research also reported the alternation in mitochondria during aging, involved in OXPHOS and mPTP proteins suppression, calcium homeostasis alterations, and metabolites catabolism breakdown (<xref ref-type="bibr" rid="B19">Fu et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B62">Stauch et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B49">Pfanner et&#x20;al., 2019</xref>). However, there is seldom a systematic report for mitochondrial alternation under effect of polyamines during the aging process. In this study, we worked to reveal the effect of polyamines during the age-associated myocardial pathological changes by proteomic strategy, aiming to find the clue to the mechanism of heart&#x20;aging.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec id="s2-1">
<title>Animal Care and Polyamines Administration</title>
<p>The male Wistar rats aged 3&#xa0;months (young, Y) and 24&#xa0;months (old, O) were purchased from the Animal Center of Harbin Medical University. All procedures conformed to the Guide for Care and Use of Laboratory Animals published by the China National Institutes of Health, and the study protocols involving the use of animals were approved by the Institutional Animal Center of Harbin Medical University. The old rats were randomly divided into old control (O, <italic>n</italic>&#x20;&#x3d; 8), spermine (Spm, <italic>n</italic>&#x20;&#x3d; 8), and spermidine (Spd, <italic>n</italic>&#x20;&#x3d; 8) groups, they were injected intraperitoneally with saline, spermine (2.5&#xa0;mg/kg), and spermidine (10&#xa0;mg/kg) for 6&#xa0;weeks, respectively, young rats injected with saline were assigned to young control (Y, <italic>n</italic>&#x20;&#x3d; 8). Spm and Spd were purchased from Sigma-Aldrich (St. Louis, MO, United&#x20;States), and the optimal concentration used was performed as previously described (<xref ref-type="bibr" rid="B74">Zhang et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B8">Chai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B68">Wang et&#x20;al., 2020a</xref>; <xref ref-type="bibr" rid="B70">Wang et&#x20;al., 2020b</xref>). From each experimental group we euthanized six rats to collect hearts. All animals were housed under conditions of constant temperature and humidity, a standard light/dark cycle, and free access to standard rodent chow and&#x20;water.</p>
</sec>
<sec id="s2-2">
<title>Echocardiography</title>
<p>Transthoracic echocardiography with Doppler ultrasound techniques was used to assess left ventricular systolic (LVIDs) and diastolic (LVIDd) parameters and function. Briefly, rats were anaesthetized by inhalation of 1.5%&#x2013;2% isoflurane. The measurement was performed with Acuson CV-70 (Siemens) using standard imaging planes by an observer blinded to the treatment. The parameters were obtained in M-mode tracings at the papillary muscle level or pulse doppler evaluation of the bicuspid valve and averaged using at least five continuous cardiac cycles.</p>
</sec>
<sec id="s2-3">
<title>Immunohistochemistry and Morphological Analyses</title>
<p>The IHC, Masson, and TUNEL staining were performed on formalin-fixed and paraffin-embedded cardiac tissue sections. For IHC staining of &#x3b2;-galactosidase, the tissue sections were deparaffinized, rehydrated, and antigen retrieval, and were incubated with anti-&#x3b2;-galactosidase (Santa Cruz, United&#x20;States) overnight, and then were incubated with biotinylated secondary antibody (Zhongshan, China) followed by avidin-biotin peroxidase complex according to the manufacturer&#x2019;s instructions. Finally, tissue sections were incubated with Diaminobenzidine (Sigma) until a brown color was developed. For Masson staining, the sections were visualized at 40&#xd7; magnification, and volume fraction of collagen (VFC) fibril structures were quantified from three sections per heart. Results were averaged from five high power random fields from each section. The apoptotic myocytes were detected by TdT mediated dUTP nick end-labeling (TUNEL) assay using a Cell Death Detection Kit (Roche, Germany) according to the manufacturer&#x2019;s instructions. Briefly, the cardiac tissue sections were incubated with a TUNEL reaction mixture containing TdT and fluorescein-dUTP after permeability treatment. The TUNEL signal was detected by an anti-fluorescent antibody conjugated with alkaline phosphatase, a reporter enzyme, which catalytically generates a colored product. Three slides from each block were evaluated for percentage of apoptotic cells. Four slide fields were randomly examined with 200&#xd7; magnification. A total of 100 cells were counted in each&#x20;field.</p>
</sec>
<sec id="s2-4">
<title>Cardiac Mitochondria Isolation</title>
<p>Rat heart mitochondria were isolated at 4&#xb0;C by differential centrifugation using a mitochondrial isolation kit (Beyotime Biotechnology, Inc.). Briefly, the rat left ventricular tissue was&#x20;washed and added 10&#x20;times the isolation buffer A. The tissue was finely minced with scissors and then homogenized in the ice-cold buffer, the following processing we did as previously described (<xref ref-type="bibr" rid="B69">Wang et&#x20;al., 2014</xref>). At last, the homogenate was centrifuged at 10,000&#xa0;g and the pellet was resuspended in ice-cold isolation buffer B prior to the ultrastructural analysis and mitochondrial respiration function assessment.</p>
</sec>
<sec id="s2-5">
<title>Transmission Electron Microscopy</title>
<p>Isolated mitochondria: The cardiac mitochondrial homogenate was centrifuged at 3000&#xa0;g and the pellet was fixed in 3% glutaraldehyde for 2&#x2013;4&#xa0;h at 4&#xb0;C, then washed, dehydrated, embedded in resin, and sectioned. The sections were stained with uranyl acetate and lead nitrate and then visualized with an electron microscope (S4800 Hitachi, Tokyo, Japan).</p>
</sec>
<sec id="s2-6">
<title>Measurement of Mitochondrial Respiration Function</title>
<p>Mitochondrial oxygen consumption was measured using a Clark-type oxygen electrode (Hansatech Instruments, Norfolk, United&#x20;Kingdom) in mitochondrial respiration buffer. Pyruvate (5&#xa0;mM) and malate (5&#xa0;mM) were used as substrates for complex I-containing mitochondria at a final concentration of 500&#xa0;&#xb5;g protein/mL. Mitochondrial State 3 respiration, State 4 respiration, respiratory control ratio (RCR), ADP/O ratio, and proton leakage were measured as previously described (<xref ref-type="bibr" rid="B69">Wang et&#x20;al., 2014</xref>).</p>
</sec>
<sec id="s2-7">
<title>Measurement of Antioxidant Enzyme Activity</title>
<p>Superoxide dismutase (SOD) activity in cardiac tissue was measured using commercial kits (SOD: A001-3-1; Jiancheng Bio. Institute, Nanjing, China) with a spectrophotometer (Perkin- Elmer, Norwalk, CT, United&#x20;States). Protein concentration was measured using the bicinchoninic acid method (Pierce, Rockford, United&#x20;States) with bovine serum albumin (BSA) as a standard.</p>
</sec>
<sec id="s2-8">
<title>Measurement of ROS</title>
<p>ROS generation was measured by dihydroethidium (DHE) staining assay (Cat No. S0063, Beyotime, China). Briefly, frozen tissue sections of cardiac tissues were incubated with 5&#xa0;&#x3bc;mol/L DHE at 37&#xb0;C for 30&#xa0;min, then washed with PBS three times and analyzed using a fluorescence microscope. Images were taken with an Olympus FluoView FV1000 fluorescence microscope (Olympus Optical Co., Ltd., Takachiho, Japan) at an excitation wavelength of 535&#xa0;nm, and the maximum emission wavelength is 610&#xa0;nm.</p>
</sec>
<sec id="s2-9">
<title>Mitochondria Protein Extraction, Trypsin Digestion, and iTRAQ Labeling</title>
<p>The mitochondria extracted in rat cardiomyocytes were divided into Y, O, Spm, and Spd. Each sample was mixed by multiple parallel samples, and each group of technologies was repeated once. All the reagents and buffers needed for iTRAQ labeling and cleaning were purchased from Applied Biosystems (Foster&#x20;City, CA, United&#x20;States). The iTRAQ labeling protocol was referred to the manufacturer&#x2019;s instructions. In brief, mitochondrial proteins were extracted by 8&#xa0;M Urea supplemented with 10&#xa0;mM DTT, pH 8.5 (Amesco St. Louis, MO, United&#x20;States) and concentration was determined by the Bradford assay. Proteins were dissolved, denatured, alkylated, and digested with trypsin (Promega) at&#x20;37&#xb0;C overnight. To label peptides with iTRAQ reagent, 1 unit of label (defined as the amount of reagent required to&#x20;label&#x20;100&#xa0;&#x3bc;g protein) was thawed and reconstituted in 150&#xa0;&#x3bc;l of isopropanol. The digestions from CSM<sub>100</sub> and SBM were labeled with 114 and 116 iTRAQ reagents, respectively, and this reaction was repeated with 115 and 117 iTRAQ reagents again to guarantee the accuracy of quantitation. Moreover, a strong cation exchange (SCX) column was used for (Applied Biosystems) separating the mixed peptides.</p>
</sec>
<sec id="s2-10">
<title>Analysis by Q-Exactive Mass Spectrometer and Data Processing</title>
<p>The fractionated peptides were analyzed by a Q-Exactive mass spectrometer fitted with a nano-liquid chromatography system. The eluent was introduced directly to a Q-Exactive mass spectrometer via EASY-Spray ion source. As for data processing, the Proteome Discoverer software 1.3 was employed to interpret raw data and protein quantitation. The rat protein database was downloaded from Uniprot database and combined with the reversed sequences and sequences of widely spread contaminants, such as human keratins for false discovery rate (FDR) control. Finally, the FDR was set to 0.01 to get high confidence results.</p>
</sec>
<sec id="s2-11">
<title>Validation of iTRAQ Results by Western Blotting</title>
<p>The mitochondrial protein concentration was measured by BCA Protein Assay Reagent Kit (Beyotime, Nantong, China). Samples containing total mitochondrial protein were separated by 10% (w/v) SDS-PAGE and transferred onto a PVDF membrane (Millipore, Bedford, MA, United&#x20;States) (details are in Western Blotting Assay section). The following antibodies were used: Antibodies for PDK4 (Cat&#x23; 12949-1-AP), HADHA (Cat&#x23; 10758-1-AP), Annexin 6 (Cat&#x23; 12542-1-AP), NNT (Cat&#x23; 13442-2-AP), and COX-IV (Cat&#x23; 66110-1-Ig) were obtained from Proteintech (Wuhan, Hubei, China). The secondary antibody (alkaline phosphatase-conjugated anti-rabbit IgG) was from Promega Corporation (Madison, WI, United&#x20;States). The intensities of the protein bands were quantified using a Bio-Rad ChemiDocTM EQ densitometer and Bio-Rad Quantity One software (Bio-Rad, Hercules, United&#x20;States).</p>
</sec>
<sec id="s2-12">
<title>Bioinformatics Analysis</title>
<p>Gene Ontology (GO) provides a controlled vocabulary to describe the attributes of genes and gene products in any organism and is applied for cardiovascular research (<xref ref-type="bibr" rid="B36">Lovering et&#x20;al., 2009</xref>). Combining the GO and Uniprot database, the function and localization was annotated for the differentially expressed proteins. The protein-protein interaction networks (PPI) were analyzed in STRING online database v11.5 (<ext-link ext-link-type="uri" xlink:href="http://www.string-db.org/">http://www.string-db.org/</ext-link>).</p>
</sec>
<sec id="s2-13">
<title>Isolated and Culture of Neonatal Cardiomyocytes</title>
<p>Neonatal rat cardiomyocytes (NRCMs) were isolated and cultured by standard methods as previously described (<xref ref-type="bibr" rid="B72">Wei et&#x20;al., 2016</xref>). Three days after being seeded, these cardiomyocytes were divided randomly into the following. Control group: cells cultured under normal incubation conditions. H<sub>2</sub>O<sub>2</sub> group (H<sub>2</sub>O<sub>2</sub>-induced cell senescence group): cardiomyocytes were pre-treated with 40&#xa0;&#x3bc;M H<sub>2</sub>O<sub>2</sub> for 4&#xa0;h, then cultured for 24&#xa0;h the same as the control group. H<sub>2</sub>O<sub>2</sub>-Spm, H<sub>2</sub>O<sub>2</sub>-Spd, and H<sub>2</sub>O<sub>2</sub>-DAC groups: cardiomyocytes were pre-treated with 40&#xa0;&#x3bc;M H<sub>2</sub>O<sub>2</sub> for 4&#xa0;h, then incubated with 20&#xa0;&#x3bc;M Spm, 10&#xa0;&#x3bc;M Spd, or 1&#xa0;mM dichloroacetate (DCA) for 24&#xa0;h, respectively. H<sub>2</sub>O<sub>2</sub>-Spd-DFMO group: before the cells were treated with 40&#xa0;&#x3bc;M H<sub>2</sub>O<sub>2</sub>, they were pre-incubated with the 5&#xa0;mM difluoromethylornithine (DFMO, an inhibitor of ODC) for 1&#xa0;h. The followed treatment was the same as the H<sub>2</sub>O<sub>2</sub>-Spd group. Both DFMO and DCA were purchased from Sigma-Aldrich (St. Louis, MO, United&#x20;States), and the optimal concentration applied was performed as previously described (<xref ref-type="bibr" rid="B68">Wang et&#x20;al., 2020a</xref>).</p>
</sec>
<sec id="s2-14">
<title>Senescence-Associated &#x3b2;-Galactosidase Staining</title>
<p>Cellular senescence was determined by SA-&#x3b2;-gal staining. Staining was performed using SA-&#x3b2;-gal staining kit (Beyotime, Haimen, China) according to the manufacturer&#x2019;s guidelines. Positive staining was evaluated after 12&#x2013;16&#xa0;h incubation at 37&#xb0;C in a CO<sub>2</sub>-free atmosphere. The blue stained cells from 10 different fields were counted with results presented as a percentage of positive&#x20;cells.</p>
</sec>
<sec id="s2-15">
<title>JC-1 Staining</title>
<p>JC-1 (Beyotime Biotech, C2006), a sensitive fluorescent probe for &#x394;&#x3a8;m, was used to measure the &#x394;&#x3a8;m of cardiomyocytes. In healthy cells with high mitochondrial &#x394;&#x3a8;m, JC-1 forms aggregates with intense red fluorescence; in apoptotic or unhealthy cells with low &#x394;&#x3a8;m, JC-1 remains in the monomeric form, which shows green fluorescence. According to the manufacturer&#x2019;s directions, the cells were incubated with JC-1 staining solution (5&#xa0;&#x3bc;g/ml) for 20&#xa0;min at 37&#xb0;C and then washed twice with Tyrode standard solution. The images were viewed and scanned under laser confocal microscopy (OLYMPUS, FV1000, Japan) at 488&#xa0;nm excitation and 530&#xa0;nm emission for green, and at 543&#xa0;nm excitation and 590&#xa0;nm emission for red. The ratio of red to green fluorescence was calculated as &#x394;&#x3a8;m. Mitochondrial depolarization is indicated by a reduction in the red/green fluorescence intensity ratio. Image processing and analysis were performed with ImageJ software.</p>
</sec>
<sec id="s2-16">
<title>Statistics</title>
<p>All statistical analyses were performed using SPSS 17.0 (SPSS, Chicago, IL, United&#x20;States). Values are expressed as mean&#x20;&#xb1; SEM. Mann-Whitney U Test was used for comparing between two groups for non-normally distributed data. Comparisons between the mean of three or more groups were done by one-way ANOVA. Correlation analysis was performed by linear regression. Differences were considered significant at <italic>p</italic>&#x20;&#x3c;&#x20;0.05.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Result</title>
<sec id="s3-1">
<title>Polyamines Protected Cardiac Function in the Aging Heart</title>
<p>To investigate the effect of polyamines on age-related cardiac changes, we first examine the cardiac function between young (3-months-old) and old (24-month-old) rat hearts with or without Spm and Spd supplementation. Echocardiographic evaluation revealed a significant increase in the left ventricular internal diameter at end-diastole (LVIDd) and end-systole (LVIDs), as well as a decrease in the shortening fraction (FS) and ejection fraction (EF) in old rats compared with young rat hearts. Spm and Spd injection reversed aging-induced unfavorable changes in cardiac function (<xref ref-type="fig" rid="F1">Figures 1A&#x2013;D</xref>). Furthermore, SA-&#x3b2;-gal was stained in the cytosol of the cardiomyocyte, the aged heart showed significantly higher &#x3b2;-gal staining when compared to the young heart. Spm and Spd supplementation overtly decreased aging-induced &#x3b2;-gal staining elevation in old hearts (<xref ref-type="fig" rid="F1">Figures 1E,F</xref>). Disordered collagen fiber network was also observed in old rat hearts, and collagen volume fraction (CVF) was higher than young rat hearts. After Spm or Spd complement, CVF of old rat hearts was decreased to a greater extent (<xref ref-type="fig" rid="F1">Figures 1G,H</xref>). Similarly, a significant increase of p21 was seen in old hearts compared with the young, and the age-related expression of p21 was significantly attenuated by Spm and Spd treatment in the aged heart (<xref ref-type="fig" rid="F1">Figures 1I,J</xref>). These findings suggested that Spm and Spd treatments can effectively inhibit the decrease of age-related heart function and cardiomyocytes&#x20;aging.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Cardiac function in polyamines-treated old rats. <bold>(A,B)</bold> Left ventricular internal diameter at end-diastole (LVIDd) and left ventricular internal diameter at end-systole (LVIDs) in indicated groups (<italic>n</italic>&#x20;&#x3d; 8). <bold>(C)</bold> Fractional shortening (FS) and <bold>(D)</bold> eject fraction (EF) were measured by tissue Doppler imaging of the mitral annulus (<italic>n</italic>&#x20;&#x3d; 8). <bold>(E)</bold> The expression of &#x3b2;-gal was assayed by immunohistochemical (IHC) staining, staining is shown, scale bar &#x3d; 50&#xa0;&#x3bc;m. <bold>(F)</bold> Quantitative analysis of &#x3b2;-gal positive cells (<italic>n</italic>&#x20;&#x3d; 8). <bold>(G,H)</bold> Masson staining and collagen volume fraction represent interstitial fibrotic areas in the left ventricle midwall sections in indicated groups, scale bar &#x3d; 100&#xa0;&#x3bc;m (<italic>n</italic>&#x20;&#x3d; 8). <bold>(I,J)</bold> The expression of p21 was assayed by Western blotting (WB), GAPDH is used as the internal loading control (<italic>n</italic>&#x20;&#x3d; 6&#x2013;8). Mean&#x20;&#xb1; SEM; <italic>p</italic>-values correspond to one-way ANOVA; &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05 vs. Y; <sup>&#xa7;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, and <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05 vs. O.</p>
</caption>
<graphic xlink:href="fcell-10-840389-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Polyamines Improved Mitochondrial Function in the Aging Heart</title>
<p>To evaluate the mitochondrial function under polyamines treatment, transmission electron microscope (TEM) was applied to observe the changes of mitochondrial morphology in cardiomyocytes. Mitochondria are longitudinally arranged in the spaces between myofibrils, and mitochondrial cristae were clearly observed in young cardiomyocytes. However, the myocardial fiber structure was disordered, mitochondria were swollen, and mitochondrial matrix density was decreased in aged rats. In contrast, the polyamines treatment heart showed clear cardiac sarcomeres and a dense mitochondrial matrix, only a few mitochondria were showed mildly swollen (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). Furthermore, we isolated cardiac mitochondria and measured respiratory function in rats, including the respiratory rates of State 3 and State 4, the respiratory control rates (RCR), ADP/O ratio, and proton leakage using pyruvate/malate as substrates. Proton leakage (H<sup>&#x2b;</sup>) was measured as oligomycin-inhibited State 3 respiration, which was normalized to young hearts. We found that the State 3 respiratory rate, RCR, and ADP/O ratio were significantly decreased, and proton leakage was increased in the old myocardial mitochondria compared with the young group (<italic>p</italic>&#x20;&#x3c; 0.05 for all). State 3 respiratory rate, RCR, and ADP/O ratio were higher, and the oxidative phosphorylation independent proton leakage was lower in cardiac mitochondria of polyamines treated old rat hearts than that in normal old hearts. However, there were no significant differences in the mitochondrial State 4 respiratory rate among any of the experimental groups (<xref ref-type="fig" rid="F2">Figures 2B&#x2013;E</xref>). As we know, mitochondria play a significant role in energy metabolism, redox balance, and apoptosis regulation (<xref ref-type="bibr" rid="B27">Jang et&#x20;al., 2018</xref>). Thus, we evaluated the effect of polyamines on apoptosis in aging hearts by TUNEL assay. The results showed a significant increase in the number of TUNEL-positive cardiomyocytes in cardiac tissue from old hearts compared with young hearts, and polyamines supplementation inhibited such an increase (<xref ref-type="fig" rid="F2">Figures 2F,G</xref>). Furthermore, Spm and Spd treatment significantly attenuated oxidative stress in aging myocardium, evidenced by decrease in SOD activity (<xref ref-type="fig" rid="F2">Figure&#x20;2H</xref>) and reduction in the fluorescent intensity of DHE (<xref ref-type="fig" rid="F2">Figure&#x20;2I</xref>). These data suggest that polyamines improve mitochondrial respiration function through inhibiting oxidative stress and preventing cell apoptosis in myocardium of the aged&#x20;rat.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Mitochondrial function in polyamines-treated old rats. <bold>(A)</bold> Ultrastructure changes of cardiomyocytes under transmission electron microscope (TEM), scale car &#x3d; 2&#xa0;&#x3bc;m (<italic>n</italic>&#x20;&#x3d; 3). <bold>(B&#x2013;E)</bold> Mitochondrial oxidative phosphorylation (OXPHOS) efficiency was evaluated in the rat myocardium. Measurements included <bold>(B)</bold> mitochondrial oxygen consumption States 3 and State 4; <bold>(C)</bold> respiratory control rate (RCR); <bold>(D)</bold> ADP/O ratio and <bold>(E)</bold> proton leakage. Respiration was induced with pyruvate/malate (5&#xa0;mM each) as energizing substrates and ADP (200&#xa0;&#x3bc;M) to initiate State 3 respiration (<italic>n</italic>&#x20;&#x3d; 8). <bold>(F)</bold> Nuclei with brown staining indicate TUNEL-positive cells, while the normal nuclei are blue, scale bar &#x3d; 50&#xa0;&#x3bc;m. <bold>(G)</bold> Quantitative results of the percentage of TUNEL-positive nuclei to total nuclei in different groups (<italic>n</italic>&#x20;&#x3d; 5). <bold>(H)</bold> SOD activities of cardiac tissues were detected by SOD activity assay (<italic>n</italic>&#x20;&#x3d; 5). <bold>(I)</bold> Representative images of ROS changes in myocardial tissues detected by DHE staining assay, scale bar &#x3d; 50&#xa0;&#x3bc;m. Fluorescence intensity analysis of ROS changes in myocardial tissues (<italic>n</italic>&#x20;&#x3d; 5). Mean&#x20;&#xb1; SEM; <italic>p</italic>-values correspond to one-way ANOVA; &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05 vs. Y; <sup>&#xa7;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, and <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05 vs. O.</p>
</caption>
<graphic xlink:href="fcell-10-840389-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Mitochondrial Proteomic Alteration After Polyamines Treatment in the Aging Heart</title>
<p>To evaluate potential correlations between polyamines and mitochondrial, we isolated mitochondria from four different groups, including Y, O, Spm, and Spd. We first observed the ultra-structure changes of isolated mitochondria with TEM, and found the mitochondria isolated from young hearts showed intact mitochondrial inner and outer membranes, cristae arranged neatly and matrix dense, while the mitochondria from old hearts showed matrix loose, ruptured inner and outer membrane, cristae decreasing or disappearance, and some of mitochondria changed to vacuole. In contrast, Spm and Spd complement significantly retarded the ultra-structure changes of the aged heart mitochondria. Intact mitochondrial membranes, dense matrix, and more clear mitochondrial structure were also observed after polyamines treatment (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). Then, the isolated mitochondria were labeled with iTRAQ regent and analyzed by Q-Elite. Principal component analysis (PCA) of the processed datasets was performed to visualize the clustering trends among the samples selected. In the score plot of PCA, the different groups Y, O, Spm, and Spd were well differentiated (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). In total, 36,251 tandem mass spectra were captured and searched against the Uniprot rat protein database using stringent matching criteria, resulting in the confident identification of 1355 gene products. According to the report ions, 364 differentially expressed proteins were identified, of which 95 proteins with more than 1.5 folds were selected (<xref ref-type="sec" rid="s11">Supplementary Table S1</xref>). These proteins represented the difference among Y vs. O, Spm vs. O, and Spd vs. O. There were 53 upregulated (ratio &#x3c; 1.50) proteins and 19 downregulated (ratio &#x3c; 0.67) proteins between young and old rats. As for Spm injection group, there were 6 upregulated proteins and 18 downregulated proteins. Whereas 9 upregulated proteins and 13 downregulated proteins were identified in the Spd injection group. Additionally, some differentially expressed proteins were identified in both Spm or Spd groups, such as pyruvate dehydrogenase kinase (PDK4), protein Hbb-b1, and protein RT1-A1. Owing to contamination during mitochondria isolation, the localization information of all the differentially expressed proteins should be annotated. To do so, GO, a well-established knowledge database, was employed to give systematic annotation for these proteins. As a result, there are 75 proteins localized in mitochondria, which is about 20% in all 364 differentially expressed proteins (<xref ref-type="fig" rid="F3">Figure&#x20;3C</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>). While proteins localized in cytoplasm and extracellular space may be contaminants in mitochondria isolation. The function of identified proteins was also annotated by GO, which includes metabolism, translation, transport, apoptosis, and oxidative phosphorylation, and most of these items are tightly related with mitochondrial physiological function (<xref ref-type="fig" rid="F3">Figure&#x20;3D</xref>). Among all these 75 mitochondrial proteins, 13 proteins were differentially expressed more than 1.5-fold, Venn diagrams represent the distribution of protein identifications for each group compared to the old (<xref ref-type="fig" rid="F3">Figures 3E,F</xref>). Furthermore, heatmap analysis of the 75 mitochondrial proteins revealed notable differences between Y, O, Spm, and Spd, and some proteins expressed in the polyamines treatment group were remarkably close to the young group (<xref ref-type="fig" rid="F3">Figure&#x20;3G</xref>). In summary, our results suggested that polyamines treatment might have an effect on alleviating cardiac&#x20;aging.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Bioinformatics analysis of cardiac mitochondrial proteome. <bold>(A)</bold> Ultrastructure changes of isolated cardiac mitochondria under TEM. A sizable proportion of extracts were mitochondria with intact membrane and cristae, scale bar &#x3d; 2&#xa0;&#x3bc;m (<italic>n</italic>&#x20;&#x3d; 3). <bold>(B)</bold> Principal component analysis (PCA) was built based on 364 protein measurements. Axes show clear differentiation among samples, a different colored circle represents each sample group (<italic>n</italic>&#x20;&#x3d; 3). <bold>(C)</bold> The distribution of identified proteins localization by GO. <bold>(D)</bold> The distribution of function of identified proteins by GO. <bold>(E)</bold> Venn diagram showing the overlap between Y vs. O, Spm vs. O, and Spd vs. O in 75 mitochondrial proteins. <bold>(F)</bold> Venn diagram showing 13 proteins which expressed more than 1.5-fold. <bold>(G)</bold> Heatmap of protein levels of identified proteins (<italic>n</italic>&#x20;&#x3d; 3).</p>
</caption>
<graphic xlink:href="fcell-10-840389-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Effects of Polyamines on Mitochondrial Biological Processes in the Aging Heart</title>
<p>Next, the MetaCore tool was used to study canonical pathways differentially regulated by Spm and Spd treatment in aged rat mitochondria, respectively. Aging gave the most alteration on the metabolic pathway, while the biosynthesis process and&#x20;oxidative phosphorylation were also altered when comparing young and old rat mitochondria (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). Crucial polyamines-altered biological processes include metabolic pathway, oxidative phosphorylation, and aging-related diseases (<xref ref-type="fig" rid="F4">Figures 4B,C</xref>), which means polyamines treatment has an effect on aging-related metabolic pathways and diseases. To gain more insight into the biological functions and molecular characteristics of the differentially expressed proteins, protein&#x2013;protein interactions (PPI) networks were constructed by the STRING database, which has a collection of known and predicted PPI, including direct (physical) and&#x20;indirect (functional) associations. We examined 53 mitochondrial proteins differentially expressed in young compared to old, 22 proteins followed the Spd treatment and 13 proteins followed the Spm treatment vs. old (<xref ref-type="fig" rid="F4">Figures 4D&#x2013;F</xref>). More interestingly, there were conspicuous PPI among polyamines and aging. Thus, we speculate that polyamines treatment may play a significant role in regulating the mitochondrial-related metabolic mechanism and aging progress. Specially, PDK4 was obviously downregulated both in Y vs. O (Y:O &#x3d; 0.50104) and Spm vs. O (Spm:O &#x3d; 0.490375). PDK4 also has a decreasing trend after Spd treatment (Spd:O&#x20;&#x3d;&#x20;0.736708). Of note, there are certain differences in the canonical pathway and PPI networks of mitochondria proteome after Spm and Spd treatment. Spd treatment detected more differentially expressed mitochondrial proteins, indicating that Spd has a stronger regulatory effect on mitochondria in aging rats. Furthermore, we analyzed the interaction network of PDK4 from the String database, the members of which include RPS6KB1, RPS6KB2, DLD, DLAT, PDHX, PDHB, PRKCG, AKT1, AKT2, and AKT3 (<xref ref-type="fig" rid="F4">Figure&#x20;4G</xref>). Some of them have already been reported to regulate the aging process, but mitochondrial PDK4 regulation by polyamines stimulation in aging is still not clear. Thus, we paid our attention to these mitochondrial proteins for further biological verification.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Protein&#x2013;protein interactions of cardiac mitochondrial proteome. <bold>(A&#x2013;C)</bold> Canonical pathways regulated in Y vs. O, Spm vs. O, and Spd vs. O groups. <bold>(D&#x2013;F)</bold> STRING PPI analysis of differentially expressed proteins in Y vs. O, Spm vs. O, and Spd vs. O. <bold>(G)</bold> Construction of interaction network of PDK4 by the String database.</p>
</caption>
<graphic xlink:href="fcell-10-840389-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Validation Analysis of Significant Changes in Protein Abundance Induced by Polyamines in the Aging Heart</title>
<p>To confirm the result of the iTRAQ experiment, 4 differentially expressed proteins, PDK4, mitochondrial trifunctional enzyme subunit &#x3b1; (HADHA), Annexin6, and nicotinamide nucleotide transhydrogenase (NNT) were chosen for validation. In addition to PDK4 and NNT, Annexin6 is closely associated with the cristae in the inner membrane of mitochondria (<xref ref-type="bibr" rid="B52">Rainteau et&#x20;al., 1995</xref>) and HADHA catalyzes the last three steps of mitochondrial beta-oxidation of long-chain fatty acids (<xref ref-type="bibr" rid="B33">Liang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B1">Adeva-Andany et&#x20;al., 2019</xref>). Results showed the relative protein level of PDK4, NNT, Annexin6, and HADHA, as normalized to COX-IV. As expected, the results of Western blotting were in line with our bioinformatic analysis of mitochondrial proteome. Compared with the old hearts, PDK4 was downregulated and NNT was upregulated in both Spm and Spd treated groups, and PDK4 differed significantly (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>). However, the HADHA level was upregulated and Annexin 6 was downregulated in only the Spd treated group, but no response to Spm supplementation (<xref ref-type="fig" rid="F5">Figures 5C,D</xref>). Hence, our results suggested that the protected effects of polyamines in aging cell mitochondria were associated with mitochondrial PDK4 protein.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Validation of differentially expressed proteins. <bold>(A&#x2013;D)</bold> WB analysis of PDK4, NNT, Annexin 6, and HADHA protein level in myocardial tissue of Y, O, Spm, or Spd-treated rats (top); histogram shows the expression levels of the four proteins as determined by densitometric analysis (bottom), mitochondrial markers protein (COX IV) is used as the internal loading control (<italic>n</italic>&#x20;&#x3d; 6). Mean&#x20;&#xb1; SEM; <italic>p</italic>-values correspond to one-way ANOVA; &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05 vs. Y; <sup>&#xa7;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, and <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05 vs. O.</p>
</caption>
<graphic xlink:href="fcell-10-840389-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Polyamines Retard Cell Aging Through Downregulating PDK4 in NRCMs</title>
<p>Following our observation that PDK4 level reduced after polyamines supplementation, we further investigated the correlation between PDK4 and polyamines in aging cardiomyocytes. Primary culture neonatal rat cardiomyocytes (NRCMs) were induced aging by H<sub>2</sub>O<sub>2</sub>. Cell aging was identified by SA-&#x3b2;-gal staining and p21 expression level. We found that aging cardiomyocytes showed enlarged volume, flattened morphology, and more SA-&#x3b2;-gal positive cells. The expression of p21 was increased obviously more than that in the control group, while Spm and Spd treated groups showed a decrease in SA-&#x3b2;-gal positive cells and p21 expression. Difluoromethylornithine (DFMO, an inhibitor of ODC) treatment abolished the Spd-mediated decrease (<xref ref-type="fig" rid="F6">Figures 6A&#x2013;D</xref>). We further observed a significant increase in the expression of PDK4 after H<sub>2</sub>O<sub>2</sub> induction, and polyamines treatment lowered the expression. In addition, DFMO abolished the Spd-induced decrease of PDK4 expression (<xref ref-type="fig" rid="F6">Figures 6C,D</xref>). These data suggested that polyamines retard cell aging partly through inhibiting PDK4 in NRCMs. As we know, a hallmark of cardiac aging is total number of cardiomyocytes decreased by apoptosis (<xref ref-type="bibr" rid="B6">Broughton et&#x20;al., 2018</xref>). To elucidate the role of Spm and Spd in H<sub>2</sub>O<sub>2</sub>-induced cell apoptosis, we evaluated the loss of &#x394;&#x3c8;m by JC-1 staining (<xref ref-type="fig" rid="F6">Figures 6E,F</xref>) and assessed Cytochrome-C (Cyt-C) and BCL2 expression by Western blotting (<xref ref-type="fig" rid="F6">Figures 6G,H</xref>). JC-1 assay showed that compared to the control group, &#x394;&#x3c8;m in the H<sub>2</sub>O<sub>2</sub> group was notably compromised, presenting as a large area of green fluorescence. Regarding protein expression, the expression level of Cyt-C was elevated accompanying declining levels of BCL2 expression after H<sub>2</sub>O<sub>2</sub> pre-treatment. As expounded in <xref ref-type="fig" rid="F6">Figure&#x20;6</xref>, pre-treating with 10&#xa0;&#x3bc;M Spm or 20&#xa0;&#x3bc;M Spd before the cell incubation with H<sub>2</sub>O<sub>2</sub> protected the cells against apoptosis, showing &#x394;&#x3c8;m and BCL2 level elevation and Cyt-C expression reduction. DCA, an inhibitor of PDK4, was utilized to assess the influence of PDK4 on H<sub>2</sub>O<sub>2</sub>-induced apoptosis. Accordingly, DCA treatment got the same trend with Spm and Spd treated groups (<xref ref-type="fig" rid="F6">Figures 6E&#x2013;H</xref>). Hence, the effect of polyamines acted as a PDK4 inhibitor to markedly prevent cardiomyocytes apoptosis after H<sub>2</sub>O<sub>2</sub>-induction.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Polyamines inhibited cardiac aging through downregulating PDK4. <bold>(A)</bold> Representative images showing the morphological changes and senescence-associated- &#x3b2;-galactosidase (SA-&#x3b2;-gal) activity in cardiomyocytes treated with H<sub>2</sub>O<sub>2</sub>, H<sub>2</sub>O<sub>2</sub>-Spm, H<sub>2</sub>O<sub>2</sub>-Spd, and H<sub>2</sub>O<sub>2</sub>-Spd-DFMO, scale bar &#x3d; 20&#xa0;&#x3bc;m. <bold>(B)</bold> Quantitative analysis of SA-&#x3b2;-gal-positive cells percentage (<italic>n</italic>&#x20;&#x3d; 4). <bold>(C)</bold> The expression of p21 and PDK4 protein evaluated by WB analysis. <bold>(D)</bold> Quantitative analysis of p21 and PDK4 level normalized to GAPDH (<italic>n</italic>&#x20;&#x3d; 4&#x2013;6). <bold>(E)</bold> Representative images of JC-1staining in cardiomyocytes treated with H<sub>2</sub>O<sub>2</sub>, H<sub>2</sub>O<sub>2</sub>-Spm, H<sub>2</sub>O<sub>2</sub>-Spd, and H<sub>2</sub>O<sub>2</sub>-DAC (an inhibitor of PDK4), respectively. Red fluorescence represents JC-1 aggregates formed in normal cells with high &#x394;&#x3c8;m, whereas green fluorescence represents JC-1 monomers in cells with low &#x394;&#x3c8;m, scale bar &#x3d; 100&#xa0;&#x3bc;m. <bold>(F)</bold> Quantitative analysis of the shift of mitochondrial red fluorescence to green fluorescence among groups. The ratio of red to green fluorescence was calculated as &#x394;&#x3a8;m (<italic>n</italic>&#x20;&#x3d; 4). <bold>(G)</bold> Cytochrome-C (Cyt-C) and BCL2 protein levels in cardiomyocytes. <bold>(H)</bold> Quantitative analysis of Cyt-C and BCL2 level normalized to GAPDH (<italic>n</italic>&#x20;&#x3d; 4&#x2013;6). Mean&#x20;&#xb1; SEM; <italic>p</italic>-values correspond to one-way ANOVA; &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05 vs. control; <sup>&#xa7;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, and <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05 vs. H<sub>2</sub>O<sub>2</sub>; <sup>&#x2020;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05 vs. H<sub>2</sub>O<sub>2</sub>-Spd.</p>
</caption>
<graphic xlink:href="fcell-10-840389-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The aim of the current study was to identify alterations in mitochondrial proteome under polyamines (Spm or Spd) stimulation with a high-throughput quantitative iTRAQ approach during the age-associated myocardial pathological changes, which may contribute to resisting cardiac aging and delaying senility. Here, we established the map of differentially expressed mitochondrial proteome of the aging heart under polyamines stimulation, in which potential candidates were discovered and given further analysis.</p>
<p>In this study, we first analyzed differentially expressed mitochondrial proteins in young and old rat hearts. We found the difference between old and young mitochondria is more than the other two groups, including 3 downregulated (MAOA, PDK4, FAM162A) and 6 upregulated (NDUFB4, PET112-like, UQCC2, UQCC3, HSP90, FUNDC2) mitochondrial proteins, which indicates mitochondrial function is complicated and regulated by multiple pathways in the mechanism of aging. These differentially expressed proteins participate in many biological processes, such as metabolic process, translation, transport, apoptotic process, and oxidative phosphorylation. It is well established that metabolic dysfunction including fatty acid (FA) metabolism and oxidative phosphorylation reduction is associated with aging and age-related diseases (<xref ref-type="bibr" rid="B61">Stanley et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B24">Hu and Liu, 2014</xref>). In addition, the biological functions of many other proteins have been suggested in mitochondrial proteomics. Ubiquinol-Cytochrome-C reductase complex assembly factor 2 (UQCC2, Y:O &#x3d; 1.540) is much higher in young rats than in old ones, which is demonstrated to modulate mitochondrial oxygen consumption, and regulate the respiratory chain activity and ATP production (<xref ref-type="bibr" rid="B7">Cambier et&#x20;al., 2012</xref>). Accordingly, we proposed that aging causes remodeling of the cardiac mitochondrial proteomics which could suppress mitochondrial metabolism and function, which leads to enhanced oxidant production, oxidative injury and the activation of oxidant signaling for cell death, and finally increase the sensitivity of the aging heart to stress. While the maintenance of mitochondrial proteomic homeostasis could be beneficial to preserve heart function in aged hearts.</p>
<p>Next, we observed the effect of Spm and Spd on mitochondrial proteome and related these to changes in mitochondrial function in aged hearts. We found that, after 6&#x20;weeks treatment with Spm launched at old age rat, 6 proteins were upregulated and 18 proteins were downregulated, while 9 proteins were upregulated and 13 proteins were downregulated in the Spd injection group. NADH-ubiquinone oxidoreductase chain (MTND5, Spm:O &#x3d; 1.749) was elevated significantly, and MTND5 is the core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). It was reported that the mutation of MTND5 is associated with cardiomyopathy, which exhibits impairment of mitochondrial complex I assemble, decrease of coupling respiration and adenosine triphosphate (ATP) generation (<xref ref-type="bibr" rid="B38">Marin-Garcia et&#x20;al., 2000</xref>; <xref ref-type="bibr" rid="B3">Ayalon et&#x20;al., 2013</xref>). Therefore, the high level of MTND5 expression in old heart with Spm-treatment suggested Spm may contribute to keep the heart healthy against aging. In contrast to Spm injection, more proteins are differentially expressed in Spd stimulation. Nicotinamide nucleotide transhydrogenase (NNT, Spd:O &#x3d; 1.571) is a nuclear gene encoded protein located in the mitochondrial inner membrane, which catalyzes mitochondrial transmembrane hydride transfer between NAD(H) and NAD(P)&#x2b; to generate NAD(P)H. It has been demonstrated that the NAD&#x2b;/NADH ratios affect the activity of the sirtuins family, which are potential mediators of the beneficial effects of calorie restriction and mediating lifespan, and an age-dependent loss of gene expression of NNT which linked to mitochondrial dysfunction (<xref ref-type="bibr" rid="B46">Olgun, 2009</xref>). Moreover, NNT increases NADPH level, which is important for antioxidant systems, biosynthesis, aging, and apoptosis (<xref ref-type="bibr" rid="B75">Zhang et&#x20;al., 2021</xref>). NNT overexpression can be used as management strategies to decrease the ratio of NADH/NAD&#x2b; and aging. Our research showed Spd increased NNT level in old hearts, which might be one of the molecular mechanisms of Spd delaying age-related mitochondrial damage. X-Prolyl Aminopeptidase 3 (XPNPEP3) is mitochondrial protein encoded by nuclear genes, which is conserved through evolution. Research revealed that loss of its ortholog gene Icp55p function increased the chronological lifespan and oxidative stress resistance while decreasing respiratory metabolism in <italic>S. cerevisiae</italic> (<xref ref-type="bibr" rid="B60">Stames and O&#x27;Toole, 2013</xref>). Thus, the low expression of XPNPEP3 (Spd:O &#x3d; 0.601) after Spd treatment would lead to apparent benefits such as improved mitochondrial function and increased stress resistance in the aging&#x20;heart.</p>
<p>Except for proteins that have changed more than 1.5-fold, some proteins also changed moderately after Spm or Spd treatment in the aging heart, such as LDHA (Spd:O &#x3d; 0.755), SCO1 (Spd:O &#x3d; 1.33068), SLC25A3 (Spm:O &#x3d; 1.311), and SLC25A4 (Spm:O &#x3d; 1.430). LDHA is involved in the sub-pathway that synthesizes (S)-lactate from pyruvate and is a key mediator of anaerobic glycolysis. Small molecule inhibition of LDHA resulted in a switch from aerobic glycolysis to oxidative phosphorylation and this metabolic shift was accompanied by an increase in mitochondrial content and cellular ATP levels in human pluripotent stem cell-derived cardiomyocytes (<xref ref-type="bibr" rid="B23">Hu et&#x20;al., 2018</xref>). In our research, Spd inhibited aging-induced LDHA elevation in rats (Spd:O &#x3d; 0.755), which indicated Spd might have a potential in promoting cardiomyocytes mitochondrial function. SCO1 is a mitochondrial copper-binding protein adding copper ions to the catalytic core of cytochrome-c oxidase (COX) (<xref ref-type="bibr" rid="B63">Stiburek et&#x20;al., 2009</xref>). However, in Sco1 mutation patients, it exhibits a combined deficiency in COX activity and total copper content (<xref ref-type="bibr" rid="B31">Leary et&#x20;al., 2013</xref>). SCO1 increasing in Spd-treated aging rats (Spd:O &#x3d; 1.33068) indicates the protected function of Spd in COX activity and cellular copper homeostasis. Adenine nucleotide translocases (ANTs) are protein families, 2 paralogs SLC25A3 (Spm:O &#x3d; 1.311) and SLC25A4 (Spm:O &#x3d; 1.430) were both upregulated in our result. ANTs could catalyze the exchange of cytoplasmic ADP with mitochondrial ATP across the mitochondrial inner membrane, playing an essential role for energy metabolism of eukaryotic cells (<xref ref-type="bibr" rid="B10">Cho et&#x20;al., 2015</xref>). SLC25A3 transports inorganic phosphate into the mitochondrial matrix, playing an essential role in the aerobic synthesis ATP (<xref ref-type="bibr" rid="B40">Mayr et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B5">Bhoj et&#x20;al., 2015</xref>). As for SCL25A4, it is reported that mutation of SCL25A4 is associated with autosomal recessive myopathy and cardiomyopathy, including cardiac hypertrophy, cardiomyocyte degeneration, and extensive sub-endocardial interstitial fibrosis (<xref ref-type="bibr" rid="B64">Strauss et&#x20;al., 2013</xref>). These results indicated that remodeling of the mitochondrial proteome in the aged rat heart can be partly reversed by exogenous polyamines supplement. Previously, we have demonstrated both Spd and Spm can inhibit the decrease of age-related mitochondrial State 3 respiratory, the increase of ROS production and cell apoptosis, and improved heart function. Therefore, we inferred polyamines prevented the changes of mitochondrial/cardiac function that are associated with aging through maintaining the homeostasis of the mitochondrial proteome. These results were also supported by other&#x2019;s findings, they demonstrated that Spd and Spm played anti-aging effects through inhibiting oxidative stress and improving mitochondrial function (<xref ref-type="bibr" rid="B18">Fischer et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B73">Xu et&#x20;al., 2020</xref>).</p>
<p>Polycationic polyamines Spd and Spm are essential for mammalian cell growth and survival. Dysfunction of them has been implicated in human health and diseases, such as cancer, inflammation, stroke, renal failure, diabetes, cardiovascular disease, cognitive impairment, and other ailments (<xref ref-type="bibr" rid="B2">Amin et&#x20;al., 2021</xref>). Mostly, Spd shares similar biological activities to Spm, but sometimes they showed a diverse mechanism in various pathological and physiological conditions or in the different cells and tissues. For instance, the effect of cardiovascular-protection and anti-aging of both Spm and Spd were performed through inducing autophagy, reducing age-associated oxidative stress, and inhibiting inflammation. The most frequently reported is that the beneficial effects of Spd are causally connected to the capacity of Spd to induce cytoprotective autophagy/mitophagy by modulating the expressions of <italic>Atg</italic> genes, promoting the acetylation of <italic>Atg</italic> genes by inhibiting EP300, and suppressing histone acetylation (<xref ref-type="bibr" rid="B37">Madeo et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B21">Ghosh et&#x20;al., 2020</xref>). Spd inhibited aging-associated pathologies, and pro-inflammatory status is closely associated with autophagy inducing, which would lead to improvement of mitochondrial metabolism and respiration as well as proteostasis (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2017</xref>). In contrast, Spm supplement prevents aging-associated pathologies, including pro-inflammatory status by inhibiting aging-associated aberrant DNA methylation (<xref ref-type="bibr" rid="B58">Soda, 2020</xref>). Spm extends the lifespan more and tends to act as free radical scavengers (<xref ref-type="bibr" rid="B40">Mayr et&#x20;al., 2007</xref>), to quench singlet molecular oxygen, and shield DNA from oxidative damage (<xref ref-type="bibr" rid="B71">Watkins et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B13">Dong et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B11">Da Pozzo et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B56">Smirnova et&#x20;al., 2018</xref>). It is noteworthy that recent research revealed that Spd has a unique role as the precursor of hypusine, a post-translational modification of the eIF5A, which is necessary for this protein to function in protein synthesis. However, no unique role for Spm has been identified unequivocally (<xref ref-type="bibr" rid="B47">Pegg, 2014</xref>). In our study, we noticed that Spd affects a wider array of mitochondrial proteins than Spm does in aged hearts. According to the biological functions and molecular characteristics, it seems that Spd treatment influenced mitochondrial protein synthesis and oxidoreductase activity, Spm has an essential role in mitochondrial electron transport and oxidative phosphorylation. The natural Spm and Spd carry nitrogen moieties, which are positively charged under physiological conditions. This feature provides them with an ability to interact with negatively charged nucleic acids and various proteins and influence critical cell functions. The number of positively charged amino groups linked with each PA are the key factors behind the PAs activity. Here, unequal effect between Spd- and Spm-treated on proteomic in the aging heart causes us to speculate that the anti-cardiac aging protection of Spd could be achieved by different mitochondrial mechanisms than Spm. In brief, Spd and Spm play a positive role on anti-cardiac aging by controlling mitochondrial proteomics homeostasis. Further investigation is needed to verify the different mechanisms of Spm and Spd action.</p>
<p>PDK4 is a negative regulator of the glycolytic enzyme pyruvate dehydrogenase (PDH) and cardiac-specific PDK4 overexpressed mice could perturb metabolism and exacerbate calcineurin-induced cardiomyopathy (<xref ref-type="bibr" rid="B76">Zhao et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B54">Sin et&#x20;al., 2015</xref>), and the deficiency of PDK4 could attenuate fat accumulation in the livers of mice fed a high-fat diet (<xref ref-type="bibr" rid="B25">Hwang et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B66">Tao et&#x20;al., 2013</xref>). In the present study, we demonstrated the significant role of PDK4 in mediating cardiac aging. Our proteomics results showed that PDK4 was downregulated both in young hearts (Y:O &#x3d; 0.501) and Spm-treated hearts (Spm:O &#x3d; 0.490). The protein verification experiment also demonstrated a similar trend of PDK4 expression to proteomics results, which means Spm could regulate the PDK4 expression directly and influence the metabolic pathway in old rat hearts. By construction of a PDK4 interaction network, we found PDK4 had a tight relationship with cardiomyocytic aging. According to the interaction network of PDK4 from the String database, DLD is involved in caloric restriction (CR)-preventable mitochondrial ROS in yeast aging process (<xref ref-type="bibr" rid="B65">Tahara et&#x20;al., 2007</xref>), and PDHX reduction is related to aging diseases, such as Alzheimer&#x2019;s disease, glucose intolerance, and cancer (<xref ref-type="bibr" rid="B42">Moreau et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B59">Stacpoole, 2012</xref>). There were many reports that indicated that the AKT family had effect on life span and regulated the aging process through eNOS and PI3K pathway (<xref ref-type="bibr" rid="B57">Smith and Hagen, 2003</xref>; <xref ref-type="bibr" rid="B17">Eto et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B45">Nojima et&#x20;al., 2013</xref>). These results suggested that polyamines retarded cardiomyocytes aging might partly depend on downregulating the expression of PDK4. In a separate cell experiment, we identified Spm and Spd could inhibit the increase of PDK4 expression and cell aging induced by H<sub>2</sub>O<sub>2</sub> in NRMCs, and the effect was abolished by the polyamines synthesis inhibitor, DFMO. Moreover, we revealed that PDK4 inhibitor DCA played an anti-apoptosis function, which is in line with Spm and Spd action in increasing mitochondrial membrane potential, upregulating Cytochrome-C expression, and downregulating BCL2 expression. All the results suggested that polyamines could promote cell survival against the cardiac aging by improving mitochondrial metabolism and function both from <italic>in vivo</italic> and <italic>in&#x20;vitro</italic>. PDK4 blocking by Spm and Spd may become a new therapeutic strategy against heart aging. Recent studies supported our conclusion. They reported that PDK4 is almost invariably upregulated in mitochondrial dysfunction-related metabolic diseases. PDK4 deficiency and DCA treatment exert a therapeutic effect on these diseases (<xref ref-type="bibr" rid="B28">Jeon et&#x20;al., 2021</xref>). In addition, knockout of PDK4 and DAC enhanced survival and improves lifespan, the salutary effects dependent on increased metabolic shifting from aerobic glycolysis to oxidative phosphorylation and reduced ROS production in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="B42">Moreau et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B43">Mouchiroud et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B53">Schaffer et&#x20;al., 2011</xref>). However, Hyyti et&#x20;al. observed that a marked decrease in PDK4 expression in aged mice, the downregulation of PDK4 may be accounted for by the suppression of the expression of cardiac PPAR&#x3b1;(<xref ref-type="bibr" rid="B26">Hyyti et&#x20;al., 2010</xref>). We speculated weakly that the paradoxical results might be associated with the different experiment model used, they performed the experiment in an isolated working mouse heart, and our research was performed in isolated cardiac mitochondrial and isolated cardiomyocytes from rats. Additional studies are needed to assure the changes of PDK4 during the progression of cardiac aging, and to elucidate the exact role of PDK4 in mitochondrial metabolic in aged hearts.</p>
<p>In conclusion, some key proteins were discovered in our findings, which provided valuable insight in possible experimental targets for understanding the effect of polyamines on aging resistance. There are some limitations to this study, that we did not perform experiments with PDK4&#x20;siRNA-mediated silencing in aging cardiomyocytes in the current study, we only used DCA to inhibit PDK4. We will further investigate the potential mechanism of anti-aging by polyamine through loss-of-function and gain-of-function mutations in&#x20;PDK4.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE[31] partner repository with the dataset identifier PXD031270.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by The Animal Center of Harbin Medical University.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>HZ, MY, and YZ performed the experimental design and most of the experiments, analyzed most of the data, drafted the manuscript, and performed manuscript editing/review. TL, PW, NC, LL, JW, XY, and YL performed parts of the experiments and data analysis. BQ performed technological support for mitochondrial proteome analysis.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This study was supported by grants from the National Natural Science Foundation of China (81170178, 82100268), Emergency Management Project of National Natural Science Foundation in China (31751004), and the Postgraduate Research Innovation Fund of Harbin Medical University (YJSCX2014-06HYD).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>We would like to thank Beijing Bioms Technology Co., Ltd. for technological support.</p>
</ack>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2022.840389/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2022.840389/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.DOCX" id="SM1" mimetype="application/DOCX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adeva-Andany</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Carneiro-Freire</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Seco-Filgueira</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Fern&#xe1;ndez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mouri&#xf1;o-Bayolo</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Mitochondrial &#x3b2;-oxidation of Saturated Fatty Acids in Humans</article-title>. <source>Mitochondrion</source> <volume>46</volume>, <fpage>73</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2018.02.009&#x201d;</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shalamanova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Wylie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abdullah</surname>
<given-names>B. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Polyamine Biomarkers as Indicators of Human Disease</article-title>. <source>Biomarkers</source> <volume>26</volume>, <fpage>77</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1080/1354750X.2021.1875506&#x201d;</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayalon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Flore</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Sam</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mitochondrial Encoded NADH Dehydrogenase 5 (MT-ND5) Gene point Mutation Presents as Late Onset Cardiomyopathy</article-title>. <source>Int. J.&#x20;Cardiol.</source> <volume>167</volume>, <fpage>e143</fpage>&#x2013;<lpage>e145</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2013.04.018</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartke</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Insulin and Aging</article-title>. <source>Cell Cycle</source> <volume>7</volume>, <fpage>3338</fpage>&#x2013;<lpage>3343</lpage>. <pub-id pub-id-type="doi">10.4161/cc.7.21.7012</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhoj</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ahrens-Nicklas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pyle</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>V. W.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Pathologic Variants of the Mitochondrial Phosphate Carrier SLC25A3: Two New Patients and Expansion of the Cardiomyopathy/Skeletal Myopathy Phenotype with and without Lactic Acidosis</article-title>. <source>JIMD Rep.</source> <volume>19</volume>, <fpage>59</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1007/8904_2014_364&#x201d;</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Broughton</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Firouzi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Khalafalla</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dimmeler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fernandez-Aviles</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Mechanisms of Cardiac Repair and Regeneration</article-title>. <source>Circ. Res.</source> <volume>122</volume>, <fpage>1151</fpage>&#x2013;<lpage>1163</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.312586&#x201d;</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cambier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rassam</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chabi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mezghenna</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Eveno</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>M19 Modulates Skeletal Muscle Differentiation and Insulin Secretion in Pancreatic &#x3b2;-Cells through Modulation of Respiratory Chain Activity</article-title>. <source>PLoS One</source> <volume>7</volume>, <fpage>e31815</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0031815</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Spermidine Prevents Heart Injury in Neonatal Rats Exposed to Intrauterine Hypoxia by Inhibiting Oxidative Stress and Mitochondrial Fragmentation</article-title>. <source>Oxid Med. Cel Longev</source> <volume>2019</volume>, <fpage>5406468</fpage>. <pub-id pub-id-type="doi">10.1155/2019/5406468&#x201d;</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Oseguera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dalal</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fathy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mallik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Raval</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Proteomic Profiling of Aging in the Mouse Heart: Altered Expression of Mitochondrial Proteins</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>474</volume>, <fpage>22</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2008.02.001</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shiratsuchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.-H.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Mitochondrial ATP Transporter Ant2 Depletion Impairs Erythropoiesis and B Lymphopoiesis</article-title>. <source>Cell Death Differ</source> <volume>22</volume>, <fpage>1437</fpage>&#x2013;<lpage>1450</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2014.230</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Da Pozzo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cavallini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Testai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calderone</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage</article-title>. <source>Oxid Med. Cel Longev</source> <volume>2017</volume>, <fpage>9536148</fpage>. <pub-id pub-id-type="doi">10.1155/2017/9536148&#x201d;</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>D.-F.</given-names>
</name>
<name>
<surname>Rabinovitch</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Cardiac Aging in Mice and Humans: the Role of Mitochondrial Oxidative Stress</article-title>. <source>Trends Cardiovasc. Med.</source> <volume>19</volume>, <fpage>213</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcm.2009.12.004</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Bradykinin Inhibits Oxidative Stress-Induced Cardiomyocytes Senescence via Regulating Redox State</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e77034</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0077034&#x201d;</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisenberg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Abdellatif</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Primessnig</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Stekovic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pendl</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Cardioprotection and Lifespan Extension by the Natural Polyamine Spermidine</article-title>. <source>Nat. Med.</source> <volume>22</volume>, <fpage>1428</fpage>&#x2013;<lpage>1438</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4222&#x201d;</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisenberg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Knauer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schauer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>B&#xfc;ttner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ruckenstuhl</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Carmona-Gutierrez</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Induction of Autophagy by Spermidine Promotes Longevity</article-title>. <source>Nat. Cel Biol</source> <volume>11</volume>, <fpage>1305</fpage>&#x2013;<lpage>1314</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1975&#x201d;</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elustondo</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Negoda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kane</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Kane</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Pavlov</surname>
<given-names>E. V.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Spermine Selectively Inhibits High-Conductance, but Not Low-Conductance Calcium-Induced Permeability Transition Pore</article-title>. <source>Biochim. Biophys. Acta (Bba) - Bioenerg.</source> <volume>1847</volume>, <fpage>231</fpage>&#x2013;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2014.10.007</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hayakawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Araki</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Age-related Changes of Calcineurin and Akt1/protein Kinase B&#x3b1; (Akt1/PKB&#x3b1;) Immunoreactivity in the Mouse Hippocampal CA1 Sector: an Immunohistochemical Study</article-title>. <source>Metab. Brain Dis.</source> <volume>23</volume>, <fpage>399</fpage>&#x2013;<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-008-9103-8&#x201d;</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ruhnau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Obst</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fl&#xf6;el</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vogelgesang</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Spermine and Spermidine Modulate T-Cell Function in Older Adults with and without Cognitive Decline <italic>Ex Vivo</italic>
</article-title>. <source>Aging</source> <volume>12</volume>, <fpage>13716</fpage>&#x2013;<lpage>13739</lpage>. <pub-id pub-id-type="doi">10.18632/aging.103527&#x201d;</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lovell</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Lynn</surname>
<given-names>B. C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Quantitative Proteomic Analysis of Mitochondria in Aging PS-1 Transgenic Mice</article-title>. <source>Cell Mol Neurobiol</source> <volume>29</volume>, <fpage>649</fpage>&#x2013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-009-9359-5&#x201d;</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujisawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kadoma</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Kinetic Evaluation of Polyamines as Radical Scavengers</article-title>. <source>Anticancer Res.</source> <volume>25</volume>, <fpage>965</fpage>&#x2013;<lpage>969</lpage>. </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sankhe</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mudgal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nampoothiri</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Spermidine, an Autophagy Inducer, as a Therapeutic Strategy in Neurological Disorders</article-title>. <source>Neuropeptides</source> <volume>83</volume>, <fpage>102083</fpage>. <pub-id pub-id-type="doi">10.1016/j.npep.2020.102083&#x201d;</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haddock Russell</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Ornithine Decarboxylase as a Biological and Pharmacological Tool</article-title>. <source>Pharmacology</source> <volume>20</volume>, <fpage>117</fpage>&#x2013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1159/000137355&#x201d;</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Linders</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kijlstra</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Garakani</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1&#x3b1; and LDHA</article-title>. <source>Circ. Res.</source> <volume>123</volume>, <fpage>1066</fpage>&#x2013;<lpage>1079</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.313249&#x201d;</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Targeting Tissue-specific Metabolic Signaling Pathways in Aging: the Promise and Limitations</article-title>. <source>Protein Cell</source> <volume>5</volume>, <fpage>21</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1007/s13238-013-0002-3&#x201d;</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jeoung</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Pyruvate Dehydrogenase Kinase Isoenzyme 4 (PDHK4) Deficiency Attenuates the Long-Term Negative Effects of a High-Saturated Fat Diet</article-title>. <source>Biochem. J.</source> <volume>423</volume>, <fpage>243</fpage>&#x2013;<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1042/bj20090390</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyyti</surname>
<given-names>O. M.</given-names>
</name>
<name>
<surname>Ledee</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>X.-H.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Portman</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Aging Impairs Myocardial Fatty Acid and Ketone Oxidation and Modifies Cardiac Functional and Metabolic Responses to Insulin in Mice</article-title>. <source>Am. J.&#x20;Physiology-Heart Circulatory Physiol.</source> <volume>299</volume>, <fpage>H868</fpage>&#x2013;<lpage>H875</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00931.2009&#x201d;</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>J.&#x20;Y.</given-names>
</name>
<name>
<surname>Blum</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Finkel</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Role of Mitochondria in Aging</article-title>. <source>J.&#x20;Clin. Invest.</source> <volume>128</volume>, <fpage>3662</fpage>&#x2013;<lpage>3670</lpage>. <pub-id pub-id-type="doi">10.1172/JCI120842&#x201d;</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeon</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Thoudam</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I. K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Loss of Metabolic Flexibility as a Result of Overexpression of Pyruvate Dehydrogenase Kinases in Muscle, Liver and the Immune System: Therapeutic Targets in Metabolic Diseases</article-title>. <source>J.&#x20;Diabetes Investig.</source> <volume>12</volume>, <fpage>21</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1111/jdi.13345&#x201d;</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kujoth</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Bradshaw</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Haroon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Prolla</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>The Role of Mitochondrial DNA Mutations in Mammalian Aging</article-title>. <source>Plos Genet.</source> <volume>3</volume>, <fpage>e24</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0030024</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lapidus</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Sokolove</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>The Mitochondrial Permeability Transition. Interactions of Spermine, ADP, and Inorganic Phosphate</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>269</volume>, <fpage>18931</fpage>&#x2013;<lpage>18936</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(17)32256-1</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leary</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Cobine</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Verdijk</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>de Krijger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>de Coo</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>COX19 Mediates the Transduction of a Mitochondrial Redox Signal from SCO1 that Regulates ATP7A-Mediated Cellular Copper Efflux</article-title>. <source>MBoC</source> <volume>24</volume>, <fpage>683</fpage>&#x2013;<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e12-09-0705</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H.-C.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.-H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Mitochondria and Aging</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>942</volume>, <fpage>311</fpage>&#x2013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1007/978-94-007-2869-1_14&#x201d;</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Cryo-EM Structure of Human Mitochondrial Trifunctional Protein</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>115</volume>, <fpage>7039</fpage>&#x2013;<lpage>7044</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1801252115&#x201d;</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>&#xc5;. B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The Aging Heart: Mitophagy at the Center of Rejuvenation</article-title>. <source>Front. Cardiovasc. Med.</source> <volume>7</volume>, <fpage>18</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2020.00018&#x201d;</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Moriguchi</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Polyamines Function in Stress Tolerance: from Synthesis to Regulation</article-title>. <source>Front. Plant Sci.</source> <volume>6</volume>, <fpage>827</fpage>. <pub-id pub-id-type="doi">10.3389/fpls.2015.00827&#x201d;</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lovering</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Dimmer</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Talmud</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Improvements to Cardiovascular Gene Ontology</article-title>. <source>Atherosclerosis</source> <volume>205</volume>, <fpage>9</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2008.10.014</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madeo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Eisenberg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pietrocola</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kroemer</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Spermidine in Health and Disease</article-title>. <source>Science</source> <volume>359</volume>. <pub-id pub-id-type="doi">10.1126/science.aan2788&#x201d;</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marin-Garcia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ananthakrishnan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goldenthal</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Pierpont</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Biochemical and Molecular Basis for Mitochondrial Cardiomyopathy in Neonates and Children</article-title>. <source>J.&#x20;Inherit. Metab. Dis.</source> <volume>23</volume>, <fpage>625</fpage>&#x2013;<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1023/a:1005638231195</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#xed;n-Fern&#xe1;ndez</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gredilla</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Mitochondria and Oxidative Stress in Heart Aging</article-title>. <source>Age</source> <volume>38</volume>, <fpage>225</fpage>&#x2013;<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-016-9933-y</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayr</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Merkel</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kohlwein</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Gebhardt</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>B&#xf6;hles</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>F&#xf6;tschl</surname>
<given-names>U.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Mitochondrial Phosphate-Carrier Deficiency: a Novel Disorder of Oxidative Phosphorylation</article-title>. <source>Am. J.&#x20;Hum. Genet.</source> <volume>80</volume>, <fpage>478</fpage>&#x2013;<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1086/511788</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller-Fleming</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Olin-Sandoval</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ralser</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Remaining Mysteries of Molecular Biology: The Role of Polyamines in the Cell</article-title>. <source>J.&#x20;Mol. Biol.</source> <volume>427</volume>, <fpage>3389</fpage>&#x2013;<lpage>3406</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2015.06.020</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreau</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Heath</surname>
<given-names>S.-H. D.</given-names>
</name>
<name>
<surname>Doneanu</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Hagen</surname>
<given-names>T. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Age-related Compensatory Activation of Pyruvate Dehydrogenase Complex in Rat Heart</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>325</volume>, <fpage>48</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.10.011&#x201d;</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mouchiroud</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Molin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kasturi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Triba</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Dumas</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>M. C.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Pyruvate Imbalance Mediates Metabolic Reprogramming and Mimics Lifespan Extension by Dietary Restriction in <italic>Caenorhabditis elegans</italic>
</article-title>. <source>Aging Cell</source> <volume>10</volume>, <fpage>39</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00640.x&#x201d;</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mu&#xf1;oz-Esparza</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Latorre-Moratalla</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Comas-Bast&#xe9;</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Toro-Funes</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Veciana-Nogu&#xe9;s</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Vidal-Carou</surname>
<given-names>M. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Polyamines in Food</article-title>. <source>Front. Nutr.</source> <volume>6</volume>, <fpage>108</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2019.00108&#x201d;</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nojima</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ichimiya</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kamimura</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Haploinsufficiency of Akt1 Prolongs the Lifespan of Mice</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e69178</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0069178</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olgun</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Converting NADH to NAD&#x2b; by Nicotinamide Nucleotide Transhydrogenase as a Novel Strategy against Mitochondrial Pathologies during Aging</article-title>. <source>Biogerontology</source> <volume>10</volume>, <fpage>531</fpage>&#x2013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-008-9190-2&#x201d;</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pegg</surname>
<given-names>A. E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The Function of Spermine</article-title>. <source>IUBMB Life</source> <volume>66</volume>, <fpage>8</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1002/iub.1237&#x201d;</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Riverol</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bandla</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Seisdedos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hewapathirana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kamatchinathan</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The PRIDE Database Resources in 2022: a Hub for Mass Spectrometry-Based Proteomics Evidences</article-title>. <source>Nucleic Acids Res.</source> <volume>50</volume>, <fpage>D543</fpage>&#x2013;<lpage>D552</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab1038&#x201d;</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfanner</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Warscheid</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wiedemann</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Mitochondrial Proteins: from Biogenesis to Functional Networks</article-title>. <source>Nat. Rev. Mol. Cel Biol</source> <volume>20</volume>, <fpage>267</fpage>&#x2013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-018-0092-0&#x201d;</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mitochondrial ROS-Modulated mtDNA: A Potential Target for Cardiac Aging</article-title>. <source>Oxid Med. Cel Longev</source> <volume>2020</volume>, <fpage>9423593</fpage>. <pub-id pub-id-type="doi">10.1155/2020/9423593&#x201d;</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quarles</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>D.-F.</given-names>
</name>
<name>
<surname>Tocchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Basisty</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gitari</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rabinovitch</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Quality Control Systems in Cardiac Aging</article-title>. <source>Ageing Res. Rev.</source> <volume>23</volume>, <fpage>101</fpage>&#x2013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2015.02.003</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rainteau</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mansuelle</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rochat</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Weinman</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Characterization and Ultrastructural Localization of Annexin VI from Mitochondria</article-title>. <source>FEBS Lett.</source> <volume>360</volume>, <fpage>80</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(95)00087-p&#x201d;</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaffer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>S. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>The Effect of Dichloroacetate on Health- and Lifespan in <italic>C. elegans</italic>
</article-title>. <source>Biogerontology</source> <volume>12</volume>, <fpage>195</fpage>&#x2013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-010-9310-7&#x201d;</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sin</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Yung</surname>
<given-names>B. Y.</given-names>
</name>
<name>
<surname>Siu</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Modulation of SIRT1-Foxo1 Signaling axis by Resveratrol: Implications in Skeletal Muscle Aging and Insulin Resistance</article-title>. <source>Cell Physiol Biochem</source> <volume>35</volume>, <fpage>541</fpage>&#x2013;<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1159/000369718</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nandi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Swamy</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Spermine and Spermidine Act as Chemical Chaperones and Enhance Chaperone-like and Membranolytic Activities of Major Bovine Seminal Plasma Protein, PDC-109</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>493</volume>, <fpage>1418</fpage>&#x2013;<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.09.148&#x201d;</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smirnova</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Bartosch</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zakirova</surname>
<given-names>N. F.</given-names>
</name>
<name>
<surname>Kochetkov</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Polyamine Metabolism and Oxidative Protein Folding in the ER as ROS-Producing Systems Neglected in Virology</article-title>. <source>Int. J.&#x20;Mol. Sci.</source> <volume>19</volume>. <pub-id pub-id-type="doi">10.3390/ijms19041219&#x201d;</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Hagen</surname>
<given-names>T. M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Vascular Endothelial Dysfunction in Aging: Loss of Akt-dependent Endothelial Nitric Oxide Synthase Phosphorylation and Partial Restoration by (R)-&#x3b1;-lipoic Acid</article-title>. <source>Biochem. Soc. Trans.</source> <volume>31</volume>, <fpage>1447</fpage>&#x2013;<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.1042/&#x201d;10.1042/bst0311447</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soda</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Spermine and Gene Methylation: a Mechanism of Lifespan Extension Induced by Polyamine-Rich Diet</article-title>. <source>Amino Acids</source> <volume>52</volume>, <fpage>213</fpage>&#x2013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-019-02733-2&#x201d;</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stacpoole</surname>
<given-names>P. W.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The Pyruvate Dehydrogenase Complex as a Therapeutic Target for Age-Related Diseases</article-title>. <source>Aging Cell</source> <volume>11</volume>, <fpage>371</fpage>&#x2013;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2012.00805.x&#x201d;</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stames</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>O&#x27;Toole</surname>
<given-names>J.&#x20;F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mitochondrial Aminopeptidase Deletion Increases Chronological Lifespan and Oxidative Stress Resistance while Decreasing Respiratory Metabolism in <italic>S. cerevisiae</italic>
</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e77234</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0077234</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanley</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Recchia</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Lopaschuk</surname>
<given-names>G. D.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Myocardial Substrate Metabolism in the normal and Failing Heart</article-title>. <source>Physiol. Rev.</source> <volume>85</volume>, <fpage>1093</fpage>&#x2013;<lpage>1129</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00006.2004&#x201d;</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stauch</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Purnell</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Villeneuve</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>H. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Data for Mitochondrial Proteomic Alterations in the Aging Mouse Brain</article-title>. <source>Data in Brief</source> <volume>4</volume>, <fpage>127</fpage>&#x2013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.dib.2015.05.004</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stiburek</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vesela</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hansikova</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hulkova</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zeman</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Loss of Function of Sco1 and its Interaction with Cytochrome C Oxidase</article-title>. <source>Am. J.&#x20;Physiology-Cell Physiol.</source> <volume>296</volume>, <fpage>C1218</fpage>&#x2013;<lpage>C1226</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00564.2008</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strauss</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>DuBiner</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zaragoza</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sengupta</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Severity of Cardiomyopathy Associated with Adenine Nucleotide Translocator-1 Deficiency Correlates with mtDNA Haplogroup</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>110</volume>, <fpage>3453</fpage>&#x2013;<lpage>3458</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1300690110</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tahara</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Barros</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Netto</surname>
<given-names>L. E. S.</given-names>
</name>
<name>
<surname>Kowaltowski</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Dihydrolipoyl Dehydrogenase as a Source of Reactive Oxygen Species Inhibited by Caloric Restriction and Involved in <italic>Saccharomyces cerevisiae</italic> Aging</article-title>. <source>FASEB j.</source> <volume>21</volume>, <fpage>274</fpage>&#x2013;<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1096/fj.06-6686com</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Genetic Inactivation of Pyruvate Dehydrogenase Kinases Improves Hepatic Insulin Resistance Induced Diabetes</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e71997</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0071997</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The Polyamines: Past, Present and Future</article-title>. <source>Essays Biochem.</source> <volume>46</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1042/bse0460001</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Spermidine Alleviates Cardiac Aging by Improving Mitochondrial Biogenesis and Function</article-title>. <source>Aging</source> <volume>12</volume>, <fpage>650</fpage>&#x2013;<lpage>671</lpage>. <pub-id pub-id-type="doi">10.18632/aging.102647&#x201d;</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Exercise Training Preserves Ischemic Preconditioning in Aged Rat Hearts by Restoring the Myocardial Polyamine Pool</article-title>. <source>Oxid Med. Cel Longev</source> <volume>2014</volume>, <fpage>457429</fpage>. <pub-id pub-id-type="doi">10.1155/2014/457429&#x201d;</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Exogenous Spermine Attenuates Rat Diabetic Cardiomyopathy via Suppressing ROS-P53 Mediated Downregulation of Calcium-Sensitive Receptor</article-title>. <source>Redox Biol.</source> <volume>32</volume>, <fpage>101514</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2020.101514&#x201d;</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watkins</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Borthwick</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Arthur</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The H9C2 Cell Line and Primary Neonatal Cardiomyocyte Cells Show Similar Hypertrophic Responses <italic>In Vitro</italic>
</article-title>. <source>
<italic>In Vitro</italic> Cell.Dev.Biol.-Animal</source> <volume>47</volume>, <fpage>125</fpage>&#x2013;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1007/s11626-010-9368-1&#x201d;</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Spermine Inhibits Endoplasmic Reticulum Stress - Induced Apoptosis: a New Strategy to Prevent Cardiomyocyte Apoptosis</article-title>. <source>Cel Physiol Biochem</source> <volume>38</volume>, <fpage>531</fpage>&#x2013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1159/000438648&#x201d;</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>T.-T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>G. K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.-Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.-L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Spermidine and Spermine Delay Brain Aging by Inducing Autophagy in SAMP8 Mice</article-title>. <source>Aging</source> <volume>12</volume>, <fpage>6401</fpage>&#x2013;<lpage>6414</lpage>. <pub-id pub-id-type="doi">10.18632/aging.103035&#x201d;</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Spermine and Spermidine Reversed Age-Related Cardiac Deterioration in Rats</article-title>. <source>Oncotarget</source> <volume>8</volume>, <fpage>64793</fpage>&#x2013;<lpage>64808</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.18334&#x201d;</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Ameliorative Effect of Ferruginol on Isoprenaline Hydrochloride-Induced Myocardial Infarction in Rats</article-title>. <source>Environ. Toxicol.</source> <volume>36</volume>, <fpage>249</fpage>&#x2013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1002/tox.23030&#x201d;</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jeoung</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Rosaaen-Stowe</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Latif</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Overexpression of Pyruvate Dehydrogenase Kinase 4 in Heart Perturbs Metabolism and Exacerbates Calcineurin-Induced Cardiomyopathy</article-title>. <source>Am. J.&#x20;Physiology-Heart Circulatory Physiol.</source> <volume>294</volume>, <fpage>H936</fpage>&#x2013;<lpage>H943</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00870.2007</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.-Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.-H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>S.-L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Role of Polyamines in Myocardial Ischemia/reperfusion Injury and Their Interactions with Nitric Oxide</article-title>. <source>Eur. J.&#x20;Pharmacol.</source> <volume>562</volume>, <fpage>236</fpage>&#x2013;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2007.01.096&#x201d;</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>